Kaija Holli

4.9k total citations
54 papers, 3.3k citations indexed

About

Kaija Holli is a scholar working on Oncology, Genetics and Cancer Research. According to data from OpenAlex, Kaija Holli has authored 54 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 22 papers in Genetics and 20 papers in Cancer Research. Recurrent topics in Kaija Holli's work include BRCA gene mutations in cancer (16 papers), Breast Cancer Treatment Studies (16 papers) and Global Cancer Incidence and Screening (14 papers). Kaija Holli is often cited by papers focused on BRCA gene mutations in cancer (16 papers), Breast Cancer Treatment Studies (16 papers) and Global Cancer Incidence and Screening (14 papers). Kaija Holli collaborates with scholars based in Finland, Sweden and United States. Kaija Holli's co-authors include Jorma Isola, Olli Kallioniemi, Heikki Joensuu, Vesa Kataja, Tapio Visakorpi, Päivi Heikkilä, Mikael Lundin, Taina Turpeenniemi‐Hujanen, Johan Lundin and Heli Nevanlinna and has published in prestigious journals such as JAMA, Nature Genetics and Journal of Clinical Oncology.

In The Last Decade

Kaija Holli

54 papers receiving 3.2k citations

Peers

Countries citing papers authored by Kaija Holli

Since Specialization

Citations

This map shows the geographic impact of Kaija Holli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaija Holli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaija Holli more than expected).

Fields of papers citing papers by Kaija Holli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kaija Holli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaija Holli. The network helps show where Kaija Holli may publish in the future.

Co-authorship network of co-authors of Kaija Holli

This figure shows the co-authorship network connecting the top 25 collaborators of Kaija Holli. A scholar is included among the top collaborators of Kaija Holli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kaija Holli. Kaija Holli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial 2014 ·The Lancet Oncology ·Jack Cuzick, Ivana Šestak, Simon Cawthorn, Hisham Hamed, Kaija Holli, Anthony Howell, John Forbes	318
2	Bone morphogenetic protein 4 expression in multiple normal and tumor tissues reveals its importance beyond development 2012 ·Modern Pathology ·Emma‐Leena Alarmo, Heini Huhtala, Tarja Korhonen, Liisa Pylkkänen, Kaija Holli, Tuula Kuukasjärvi, Seppo Parkkila, Anne Kallioniemi	48
3	Effect of surgeon's caseload on the quality of surgery and breast cancer recurrence 2012 ·The Breast ·(unknown), Heini Huhtala, Kaija Holli, Liisa Pylkkänen	9
4	Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study 2011 ·Breast Cancer Research ·Harri Sihto, Johan Lundin, Mikael Lundin, Terho Lehtimäki, Ari Ristimäki, Kaija Holli, Liisa Sailas, Vesa Kataja, Taina Turpeenniemi‐Hujanen, Jorma Isola, Päivi Heikkilä, Heikki Joensuu	181
5	Evaluation of dose–response models and parameters predicting radiation induced pneumonitis using clinical data from breast cancer radiotherapy 2005 ·Physics in Medicine and Biology ·Ioannis Tsougos, Panayiotis Mavroidis, (unknown), Kyriaki Theodorou, Ritva Järvenpää, Maunu Pitkänen, Kaija Holli, (unknown), Bengt K. Lind, Simo Hyödynmaa, C. Kappas	19
6	BARD1 variants Cys557Ser and Val507Met in breast cancer predisposition 2005 ·European Journal of Human Genetics ·Pia Vahteristo, Kirsi Syrjäkoski, Tuomas Heikkinen, Hannaleena Eerola, Kristiina Aittomäki, Karl von Smitten, Kaija Holli, Carl Blomqvist, Olli Kallioniemi, Heli Nevanlinna	32
7	Mammographic screening reduces risk of breast carcinoma recurrence 2004 ·Cancer ·Pirjo Immonen‐Räihä, (unknown), Ilmo Parvinen, Kaija Holli, Pauliina Kronqvist, Liisa Pylkkänen, Hans Helenius, Anne Kaljonen, (unknown), Pekka Klemi	11
8	Double-reading of plain radiographs – no benefit with regard to earliness of diagnosis of cancer recurrence: a randomised follow-up study 2004 ·European Journal of Cancer ·Ritva Järvenpää, Kaija Holli, Matti Hakama	2
9	Amplification of erbB2 and erbB2 expression are superior to estrogen receptor status as risk factors for distant recurrence in pT1N0M0 breast cancer: a nationwide population-based study. 2003 ·PubMed ·Heikki Joensuu, Jorma Isola, Mikael Lundin, Tiina Salminen, Kaija Holli, Vesa Kataja, Liisa Pylkkänen, Taina Turpeenniemi‐Hujanen, Karl von Smitten, Johan Lundin	161
10	A CHEK2 Genetic Variant Contributing to a Substantial Fraction of Familial Breast Cancer 2002 ·The American Journal of Human Genetics ·Pia Vahteristo, Jiřina Bártková, Hannaleena Eerola, Kirsi Syrjäkoski, (unknown), Outi Kilpivaara, Anitta Tamminen, Juha Kononen, Kristiina Aittomäki, Päivi Heikkilä, Kaija Holli, Carl Blomqvist, Jiří Bártek, Olli Kallioniemi, Heli Nevanlinna	346
11	Serum lipid levels during and after adjuvant toremifene or tamoxifen therapy for breast cancer 2000 ·Breast Cancer Research and Treatment ·Heikki Joensuu, Kaija Holli, Hanna Oksanen, Ritva Valavaara	44
12	Estrogen Receptor β Is Coexpressed with ERα and PR and Associated with Nodal Status, Grade, and Proliferation Rate in Breast Cancer 2000 ·American Journal Of Pathology ·Tero A.H. Järvinen, Markku Pelto‐Huikko, Kaija Holli, Jorma Isola	239
13	Quality control in health care: an experiment in radiotherapy planning for breast cancer patients after mastectomy 1999 ·International Journal of Radiation OncologyBiologyPhysics ·Kaija Holli, Pekka Laippala, (unknown), Maunu Pitkänen	20
14	High Cell Proliferation Activity Determined by DNA Flow Cytometry and Prognosis in Epidermoid Lung Carcinoma 1995 ·Acta Oncologica ·Tapio Visakorpi, Kaija Holli, Matti Hakama	13
15	Automated peak detection and cell cycle analysis of flow cytometric DNA histograms 1994 ·Cytometry ·Olli Kallioniemi, Tapio Visakorpi, Kaija Holli, Jorma Isola, Peter S. Rabinovitch	31
16	ElevatederbB-2 oncoprotein levels in preoperative and follow-up serum samples define an aggressive disease course in patients with breast cancer 1994 ·Cancer ·Jorma Isola, Kaija Holli, Heikki Oksa, (unknown), Olli Kallioniemi	88
17	Continuity of the doctor/patient relationship during the routine follow-up of a breast cancer patient 1993 ·Supportive Care in Cancer ·Kaija Holli, M Hakama	4
18	Biological, physical, mental and social dimensions of breast cancer: Information based on routine case notes 1993 ·European Journal of Cancer ·Kaija Holli, Matti Hakama	3
19	Association of C‐erbB‐2 protein over‐expression with high rate of cell proliferation, increased risk of visceral metastasis and poor long‐term survival in breast cancer 1991 ·International Journal of Cancer ·Olli Kallioniemi, Kaija Holli, Tapio Visakorpi, Timo Koivula, Heikki Helin, Jorma Isola	291
20	Effectiveness of routine and spontaneous follow-up visits for breast cancer 1989 ·European Journal of Cancer and Clinical Oncology ·Kaija Holli, Matti Hakama	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact